[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"stock-detail-ABUS":3,"homepage-market-summary":30,"stock-news-ABUS":172},{"ticker":4,"date":5,"profile":6,"quote":14},"ABUS","2026-10-01",{"name":7,"exchange":8,"sector":9,"industry":10,"description":11,"ceo":9,"employees":12,"headquarters":13,"founded":9},"Arbutus Biopharma Corporation Common Stock","Nasdaq",null,"PHARMACEUTICAL PREPARATIONS","Arbutus Biopharma Corp is a clinical-stage biopharmaceutical company focused on infectious diseases. The company is leveraging its extensive virology expertise to identify and develop novel therapeutics with distinct mechanisms of action, which can be combined to provide a functional cure for patients with chronic hepatitis B virus (cHBV). Its pipeline of internally developed, proprietary compounds includes imdusiran (AB-729), a GalNAc-conjugated, subcutaneously delivered ribonucleic acid interference (RNAi) therapeutic, and AB-101, its proprietary oral PD-L1 inhibitor, for the treatment of chronic hepatitis B (cHBV). In addition, the company is also focused on maximizing the opportunity for its in-house developed Lipid Nanoparticle (LNP) delivery technology.","19","Warminster, PA",{"close":15,"open":16,"high":17,"low":18,"prev_close":19,"change":20,"percent_change":21,"volume":22,"transactions":23,"vwap":24,"high_52w":25,"low_52w":26,"avg_volume_52w":27,"range_52w_percent":28,"record_count":29},4.56,4.77,4.775,4.51,4.78,-0.22,-4.6,16620277.430657,25840,4.6216,31.48,0.81999999,927730.6515260646,12.2,4827,{"status":31,"indices":32,"watchlist":74,"sectors":97,"benchmarks":152},"success",[33,41,48,55,61,68],{"symbol":34,"name":35,"price":36,"change":37,"pct_change":38,"is_up":39,"sparkline":40,"date":5},"SPX","S&P 500",7666.45,14.91,0.19,true,"0.0,3.1 2.3,5.0 4.6,8.0 6.9,10.4 9.3,13.4 11.6,9.1 13.9,11.5 16.2,13.8 18.5,16.0 20.8,10.3 23.2,9.5 25.5,2.0 27.8,2.0 30.1,5.9 32.4,6.0 34.7,3.4 37.1,7.3 39.4,8.2 41.7,9.4 44.0,8.5",{"symbol":42,"name":43,"price":44,"change":45,"pct_change":46,"is_up":39,"sparkline":47,"date":5},"NDX","NASDAQ 100",30501.56,93.06,0.31,"0.0,11.8 2.3,11.3 4.6,11.6 6.9,12.2 9.3,14.7 11.6,12.6 13.9,14.5 16.2,16.0 18.5,15.9 20.8,12.0 23.2,10.5 25.5,4.0 27.8,2.0 30.1,4.0 32.4,4.0 34.7,3.0 37.1,5.6 39.4,5.1 41.7,4.5 44.0,3.8",{"symbol":49,"name":50,"price":51,"change":52,"pct_change":53,"is_up":39,"sparkline":54,"date":5},"DJI","DOW JONES",50927,21,0.04,"0.0,2.0 2.3,3.4 4.6,6.5 6.9,8.6 9.3,10.2 11.6,7.6 13.9,8.4 16.2,10.0 18.5,13.2 20.8,11.6 23.2,12.1 25.5,10.2 27.8,11.2 30.1,12.9 32.4,13.8 34.7,11.4 37.1,13.1 39.4,13.8 41.7,16.0 44.0,15.9",{"symbol":56,"name":57,"price":58,"change":59,"pct_change":53,"is_up":39,"sparkline":60,"date":5},"COMP","NASDAQ Composite",26871.6,10.53,"0.0,9.3 2.3,10.2 4.6,11.1 6.9,13.0 9.3,14.9 11.6,12.1 13.9,13.7 16.2,16.0 18.5,16.0 20.8,11.1 23.2,10.0 25.5,3.4 27.8,2.0 30.1,5.4 32.4,5.4 34.7,3.9 37.1,6.7 39.4,6.9 41.7,6.2 44.0,6.1",{"symbol":62,"name":63,"price":64,"change":65,"pct_change":66,"is_up":39,"sparkline":67,"date":5},"RUT","RUSSELL 2000",2790.2,11.3,0.41,"0.0,2.6 2.3,2.0 4.6,3.0 6.9,6.1 9.3,8.4 11.6,7.5 13.9,8.8 16.2,10.4 18.5,11.3 20.8,10.2 23.2,11.2 25.5,10.1 27.8,8.8 30.1,12.9 32.4,13.1 34.7,12.8 37.1,14.4 39.4,15.1 41.7,16.0 44.0,15.1",{"symbol":69,"name":70,"price":71,"change":72,"pct_change":46,"is_up":39,"sparkline":73,"date":5},"VIX","CBOE VIX",16.39,0.05,"0.0,15.6 2.3,14.8 4.6,10.2 6.9,7.3 9.3,2.0 11.6,9.7 13.9,4.9 16.2,4.5 18.5,2.5 20.8,11.3 23.2,13.7 25.5,13.5 27.8,16.0 30.1,12.3 32.4,10.4 34.7,13.5 37.1,8.8 39.4,8.9 41.7,7.8 44.0,7.6",[75,82,90],{"symbol":76,"name":77,"price":78,"change":79,"pct_change":80,"is_up":39,"sparkline":81,"date":5},"NVDA","NVIDIA Corp",230.86,2.48,1.09,"0.0,13.9 7.3,16.0 14.7,14.9 22.0,6.5 29.3,10.1 36.7,7.5 44.0,2.0",{"symbol":83,"name":84,"price":85,"change":86,"pct_change":87,"is_up":88,"sparkline":89,"date":5},"AAPL","Apple Inc",330.32,-2.7,-0.81,false,"0.0,6.9 7.3,8.2 14.7,2.0 22.0,5.2 29.3,16.0 36.7,11.7 44.0,14.9",{"symbol":91,"name":92,"price":93,"change":94,"pct_change":95,"is_up":88,"sparkline":96,"date":5},"TSLA","Tesla Inc",354.11,-0.7,-0.2,"0.0,2.0 7.3,3.1 14.7,6.1 22.0,13.6 29.3,16.0 36.7,15.0 44.0,15.3",[98,103,108,113,118,123,128,133,137,142,147],{"name":99,"etf":100,"change":101,"price":102,"is_up":39},"Technology","XLK",1.05,197.81,{"name":104,"etf":105,"change":106,"price":107,"is_up":39},"Financials","XLF",0.11,53.46,{"name":109,"etf":110,"change":111,"price":112,"is_up":88},"Healthcare","XLV",-1.32,166.2,{"name":114,"etf":115,"change":116,"price":117,"is_up":88},"Consumer Cycl","XLY",-0.03,108.81,{"name":119,"etf":120,"change":121,"price":122,"is_up":88},"Consumer Staples","XLP",-0.33,80.33,{"name":124,"etf":125,"change":126,"price":127,"is_up":39},"Energy","XLE",1.95,62.7,{"name":129,"etf":130,"change":131,"price":132,"is_up":39},"Industrials","XLI",0.99,168.64,{"name":134,"etf":135,"change":121,"price":136,"is_up":88},"Materials","XLB",48.54,{"name":138,"etf":139,"change":140,"price":141,"is_up":88},"Real Estate","XLRE",-0.56,40.68,{"name":143,"etf":144,"change":145,"price":146,"is_up":39},"Utilities","XLU",0.61,39.68,{"name":148,"etf":149,"change":150,"price":151,"is_up":88},"Comm Services","XLC",-0.93,109.94,[153,158,162,167],{"ticker":154,"name":155,"price":156,"change":157,"is_up":39},"SPY","SPDR S&P 500 ETF",763.99,0.18,{"ticker":159,"name":160,"price":161,"change":46,"is_up":39},"QQQ","Invesco QQQ Trust",742.03,{"ticker":163,"name":164,"price":165,"change":166,"is_up":39},"DIA","SPDR Dow Jones ETF",508.68,0.03,{"ticker":168,"name":169,"price":170,"change":171,"is_up":39},"IWM","iShares Russell 2000",279.06,0.42,{"ticker":4,"count":173,"articles":174},10,[175,181,187,192,198,204,210,216,221,226],{"title":176,"link":177,"pubDate":178,"description":179,"source":180},"ABUS Stock Price, Quote & Chart - ChartMill","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiX0FVX3lxTE5QYWtOaHlBRHg3RFdUN1hqV3g2UUU2ZmU0Nk5PQXZLZFBfVWoyOEJaX1lxZ2FfMmpEOXFxV0JjUkRHeWdBVVlkeE1saW5YcW1BOHUzcS1hZERQbHo1ZFZj?oc=5","Wed, 30 Sep 2026 07:00:00 GMT","ABUS Stock Price, Quote & Chart ChartMill","ChartMill",{"title":182,"link":183,"pubDate":184,"description":185,"source":186},"Arbutus Biopharma Stock Price Forecast. Should You Buy ABUS? - StockInvest.us","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiSEFVX3lxTE8xb0FHcEIwQ2xnY0MzUnpwZkF4bDQ1UDdqUDFGeEYwRUM2Y2R1clhFYnB3REI5Y09hMHJTaE5kbHktTGlRMEVIMQ?oc=5","Fri, 18 Sep 2026 22:22:56 GMT","Arbutus Biopharma Stock Price Forecast. Should You Buy ABUS? StockInvest.us","StockInvest.us",{"title":188,"link":189,"pubDate":178,"description":190,"source":191},"About 23% of Arbutus shares are being bought back for $230 million. - stocktitan.net","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiwAFBVV95cUxOMGJwcGR5OUYzVEJzTmRKT3NGeUlCckl0N19uOGdWTGhlR1RndnRYdGEtNDJ5ZnlCNExJTGdOQjU4TU1BZjZkYml4dlNkdjdfVUJrWVhxVUs1dUs3dnVkSEdCRVdJa2NHNVhxQk43ai1nd1JnV0doc1RSV2tsNXRCVEZiYTdhS0FwSk9mM2dtZzhiN0hJcXVKS2M3Mk9QOGtIaFhmNmhuVUMzSTl6NkwwdUxtS2hZQjJOaEVka19mclc?oc=5","About 23% of Arbutus shares are being bought back for $230 million. stocktitan.net","stocktitan.net",{"title":193,"link":194,"pubDate":195,"description":196,"source":197},"Arbutus Biopharma (ABUS) Shares Rise on $230M Share Buyback Comp - GuruFocus","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiqgFBVV95cUxQTWZBeHdrM2Jmd0d3WmZWNGVxMkRjY2dXWjNNeEhFQzRKQkJyY0FIX2JWd09aN0VhMGFvcjVkSlM3dmFLMXFVZW9PYmZGSnBkUkI5anJkVU9FOTBGZUl6VTJvbG9GMG4xQlhWWFhrd0pab0J6X0N6V3VlMkVBTU5SdHV3UWc3Yk5OSzhsWkpQOFdQY2V3YXdjN3JGdktQcnlQN3lPdkpycU9BZw?oc=5","Wed, 30 Sep 2026 18:06:43 GMT","Arbutus Biopharma (ABUS) Shares Rise on $230M Share Buyback Comp GuruFocus","GuruFocus",{"title":199,"link":200,"pubDate":201,"description":202,"source":203},"ABUS261016C00007000 Interactive Stock Chart | ABUS Oct 2026 7.000 call Stock - Yahoo Finance","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiYEFVX3lxTE9hQWE1X1dfX2d6SEMzTDl0SWFkRTIzQlItczhmTERscFM4T3BsRDZjZjFsSUdvSER6Zll0Y3pGc29aQXQteVlXV25JenNETnlyd0dnbVluNGtzbHdWVE5xUQ?oc=5","Thu, 01 Oct 2026 08:38:10 GMT","ABUS261016C00007000 Interactive Stock Chart | ABUS Oct 2026 7.000 call Stock Yahoo Finance","Yahoo Finance",{"title":205,"link":206,"pubDate":207,"description":208,"source":209},"Arbutus Biopharma Announces Preliminary Results of US$230 Million Substantial Issuer Bid Tender Offer - Quiver Quantitative","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi0gFBVV95cUxPQUF5TVI4aDY3RHVYd3o0bTFUVjVRV0FUMlBFRXhoazE3ZDVXUEQ4Z0pxOU55d080YmxxR1FrR2xSS1hBQ2dPaTZfOGpyMUpuMlBxczk3SXRzdFNFOXdLcU5hYU1SNlpaSGR6d3JzWHA1eWI3Mm0tc0p2Q2ktZk1URG9rbllQQmY5bVQxTU8yLWFsdGhnTVBtWV8zSXA3bEdLQWgzSVNPRzA3QzVCQVhvUUMwWjY3Q01Za0tPTUdfTTZETzRBV1NBSHIwQ29xcEgyLVE?oc=5","Wed, 30 Sep 2026 11:41:00 GMT","Arbutus Biopharma Announces Preliminary Results of US$230 Million Substantial Issuer Bid Tender Offer Quiver Quantitative","Quiver Quantitative",{"title":211,"link":212,"pubDate":213,"description":214,"source":215},"SPCX Stock Extends Post-IPO Rout: Starship Launch Scrub Deepens Slide As Short Sellers Build $25B Bear Bet - Stocktwits","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiwwFBVV95cUxQVHBEWUJJR1VfX0RUZHRJN0NKZ3VFRThObGh1Wm9iMnI0WTBsZHJUTnd1cTNpdmVmNzRrbkFZa1VIcHllWVF5aU9Cb3AtYXZWdnRLS1VxTmNwQ3ZNeGxBcWcwVjVnZXVSbmg2eWxpcm9sb08ybmhfM1R3aHh3RDBJY00wVWtZZmlkN1poakktQmdiZkVzZTlCNTFremMxWlROM1N4WFItWEJmaEpHekZ3U3JFSWdpYUdxOU1MRk9XMWNBSWM?oc=5","Thu, 01 Oct 2026 00:59:35 GMT","SPCX Stock Extends Post-IPO Rout: Starship Launch Scrub Deepens Slide As Short Sellers Build $25B Bear Bet Stocktwits","Stocktwits",{"title":217,"link":218,"pubDate":219,"description":220,"source":191},"The share offer capped at $230M has expired. Arbutus (ABUS) announces final results. - stocktitan.net","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMivwFBVV95cUxNTHdaeG9wY1pBZEFub0dLOHZYX3poVVZGc05ZNDhqcEJMbDJFWXNCM0gzVGFZWG9yQy12WDk2VS1lelUzbjdvNmE3ZDB6RldqSFc3VUNrS2Q5dlhnRGdQbklzc2lMV29fSDFtWGNrZkM4NU5IRlBDUTd0N0sycGhrWTd5djhxT216R0tZZGY5Q1NHSVoyODVLN21xSVgxWmtTaWRHQ1J4QWF2bklkZ0NtMUtNNllOVzZ1bVdCdjhWTQ?oc=5","Thu, 01 Oct 2026 11:37:10 GMT","The share offer capped at $230M has expired. Arbutus (ABUS) announces final results. stocktitan.net",{"title":222,"link":223,"pubDate":224,"description":225,"source":191},"An up-to-$230M share offer expired; Arbutus Biopharma (ABUS) announced preliminary results. - stocktitan.net","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMivwFBVV95cUxOQ2s4UlpxSFFQNnRQcjI3T0F5VjQ5cGpObmg1eVhNMnhuVHdHTGNFanhkLWJDZ1NwdDZuenNxc1pJbHYtc0Y1YXAxSGlVS2tfWnllbnA4bWFiSDRSVnJzdk16eHJtczlsb2dqS1BmMTN6VEYwSFhjcllKajZyQWo5dFVpRGpHTDZFeDZWcUg1d0lHdmRwMWk4SU9BWWxMXzBsUWkxR1FrWERyOE1TSnFfVExUTW5QRjFyejQ3MHUwYw?oc=5","Wed, 30 Sep 2026 14:09:02 GMT","An up-to-$230M share offer expired; Arbutus Biopharma (ABUS) announced preliminary results. stocktitan.net",{"title":227,"link":228,"pubDate":229,"description":230,"source":231},"Arbutus Biopharma’s US$230 Million Share Buyback Oversubscribed - TipRanks","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiswFBVV95cUxQUGpObXo1WlJ1MnBZQ0xHTUN2M0tEbU9aMnJoQkUxbjRHVGFTck04NGNIbFQ5bkVyLWtpUTVuVDd4RmtnQXJyM0h6MjRfQUdlLWlYMDVMVmsyMHFpbWNrS2lSa1BEMTdnLVZWa1l1eldoNktldlNqQzBLZklBcVdnSGVDUFY5YmNqYkk1VTVZV2tsa19FcHBlS21naVUwa2FmcTNhN2txSjA3XzJtTEZJZTVsTQ?oc=5","Wed, 30 Sep 2026 12:33:55 GMT","Arbutus Biopharma’s US$230 Million Share Buyback Oversubscribed TipRanks","TipRanks"]